TOKYO -- Trans Genic, a gene analysis company that carries out preclinical trials for pharmaceutical companies, has downgraded its fiscal 2019 earnings due to the coronavirust epidemic in China.
Business trends
No lab monkey? Japan Inc waits eagerly for China goods to return
Earnings downgrades look inevitable for many companies
A monkey cloned from a gene-edited macaque with circadian rhythm disorders is seen in a lab at the Institute of Neuroscience of Chinese Academy of Sciences in Shanghai. © Reuters
Read Next
Latest on Business trends
